Search results
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 day agoThe company can leverage Horizon's existing treatments and pipeline to address unmet medical needs and command premium pricing. Strategic Collaborations:...
Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoAmgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript May 2, 2024 Amgen Inc. beats earnings...
Amgen shares soar on obesity drug optimism By Proactive Investors
Investing.com· 2 days agoAmgen Inc (NASDAQ:AMGN, ETR:AMG) shares gained almost 13% at about $314 in early trade on Friday...
Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
GuruFocus.com via Yahoo Finance· 2 days agoRelease Date: May 02, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Amgen Inc
Amgen ‘very encouraged’ by preliminary data from weight-loss-drug trial, as stock jumps
Market Watch· 3 days agoShares of Amgen Inc. rallied about 13% in the extended session Thursday after the drug manufacturer...
Amgen (NASDAQ:AMGN) Price Target Cut to $328.00
ETF DAILY NEWS· 9 hours agoAmgen (NASDAQ:AMGN – Get Free Report) had its price target reduced by Royal Bank of Canada from $332.00 to $328.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently ...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very...
Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral...
Benzinga· 2 days agoAmgen, Inc. AMGN shares rallied over 14% in Thursday’s after-hours trading after the biopharma...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 3 days ago, opens new tab on Thursday said it was very encouraged after completing an interim analysis of its...
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value...
Benzinga· 2 days agoAmgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant...
